These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30852034)

  • 41. Competing Risk Analysis of the Impact of Pedal Arch Status and Angiosome-Targeted Revascularization in Chronic Limb-Threatening Ischemia.
    Settembre N; Biancari F; Spillerova K; Albäck A; Söderström M; Venermo M
    Ann Vasc Surg; 2020 Oct; 68():384-390. PubMed ID: 32278873
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
    Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-Term Limb Salvage and Amputation-Free Survival After Femoropopliteal Bypass and Femoropopliteal PTA for Critical Ischemia in a Clinical Cohort.
    Altreuther M; Mattsson E
    Vasc Endovascular Surg; 2019 Feb; 53(2):112-117. PubMed ID: 30803415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative beta blockade is associated with increased rates of 30-day major adverse cardiac events in critical limb ischemia patients undergoing infrainguinal revascularization.
    Shannon AH; Mehaffey JH; Cullen JM; Hawkins RB; Roy R; Upchurch GR; Robinson WP
    J Vasc Surg; 2019 Apr; 69(4):1167-1172.e1. PubMed ID: 30598355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perioperative outcomes of infrainguinal bypass surgery in patients with and without prior revascularization.
    Bodewes TCF; Ultee KHJ; Soden PA; Zettervall SL; Shean KE; Jones DW; Moll FL; Schermerhorn ML
    J Vasc Surg; 2017 May; 65(5):1354-1365.e2. PubMed ID: 28190717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endovascular Therapy Provides Similar Results of Bypass Graft Surgery in the Treatment of Infrainguinal Multilevel Arterial Disease in Patients with Chronic Limb-Threatening Ischemia in All GLASS Stages.
    Casella IB; Sartori CH; Faustino CB; Vieira Mariz MP; Presti C; Puech-Leão P; De Luccia N
    Ann Vasc Surg; 2020 Oct; 68():400-408. PubMed ID: 32339688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of foot infection on infrainguinal bypass outcomes in patients with chronic limb-threatening ischemia.
    Mayor JM; Valentin W; Sharath S; Barshes NR; Chung J; Kougias P; Mills JL
    J Vasc Surg; 2018 Dec; 68(6):1841-1847. PubMed ID: 30064844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Below-knee endovascular interventions have better outcomes compared to open bypass for patients with critical limb ischemia.
    Hicks CW; Najafian A; Farber A; Menard MT; Malas MB; Black JH; Abularrage CJ
    Vasc Med; 2017 Feb; 22(1):28-34. PubMed ID: 27928034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cryopreserved Homografts in Infected Infrainguinal Fields Are Associated with Frequent Reinterventions and Poor Amputation-Free Survival.
    Wang SK; Gutwein AR; Drucker NA; Murphy MP; Fajardo A; Dalsing MC; Motaganahalli RL; Lemmon GW
    Ann Vasc Surg; 2018 May; 49():24-29. PubMed ID: 29421428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
    Desai K; Han B; Kuziez L; Yan Y; Zayed MA
    J Vasc Surg; 2021 Feb; 73(2):711-721.e3. PubMed ID: 32891809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia.
    Palena LM; Diaz-Sandoval LJ; Gomez-Jaballera E; Peypoch-Perez O; Sultato E; Brigato C; Brocco E; Manzi M
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):83-87. PubMed ID: 28648324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of JCLIMB, SPINACH, and VQI Calculators for Prediction of Two Year Survival in Patients With Chronic Limb Threatening Ischaemia After Infra-Inguinal Surgical or Endovascular Revascularisation.
    Morisaki K; Matsuda D; Guntani A; Kawanami S; Yoshino S; Inoue K; Honma K; Yamaoka T; Mii S; Yoshizumi T
    Eur J Vasc Endovasc Surg; 2024 May; 67(5):777-783. PubMed ID: 38141957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bypass versus endovascular intervention for healing ischemic foot wounds secondary to tibial arterial disease.
    Mohapatra A; Henry JC; Avgerinos ED; Boitet A; Chaer RA; Makaroun MS; Leers SA; Hager ES
    J Vasc Surg; 2018 Jul; 68(1):168-175. PubMed ID: 29336904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editor's Choice - Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial.
    Kodama A; Meecham L; Popplewell M; Bate G; Conte MS; Bradbury AW
    Eur J Vasc Endovasc Surg; 2020 Nov; 60(5):687-695. PubMed ID: 32778491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The BASIL survival prediction model in patients with peripheral arterial disease undergoing revascularization in a university hospital setting and comparison with the FINNVASC and modified PREVENT scores.
    Moxey PW; Brownrigg J; Kumar SS; Crate G; Holt PJ; Thompson MM; Jones KG; Hinchliffe RJ
    J Vasc Surg; 2013 Jan; 57(1):1-7. PubMed ID: 23040797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contemporary (2009-2014) clinical outcomes after femoropopliteal bypass surgery for chronic limb threatening ischemia are inferior to those reported in the UK Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) trial (1999-2004).
    Meecham L; Popplewell M; Bate G; Patel S; Bradbury AW
    J Vasc Surg; 2019 Jun; 69(6):1840-1847. PubMed ID: 30852037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid increase in hybrid surgery for the treatment of peripheral artery disease in the Vascular Quality Initiative database.
    Fereydooni A; Zhou B; Xu Y; Deng Y; Dardik A; Ochoa Chaar CI
    J Vasc Surg; 2020 Sep; 72(3):977-986.e1. PubMed ID: 32067877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
    J Vasc Surg; 2019 Jun; 69(6S):126S-136S. PubMed ID: 31159976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contemporary outcomes of concomitant suprainguinal bypass with infrainguinal revascularization procedures in patients with chronic limb-threatening ischemia.
    Naazie IN; Zarrintan S; Arhuidese I; Al-Nouri O; Abou-Zamzam A; Malas M
    J Vasc Surg; 2022 Mar; 75(3):989-997.e1. PubMed ID: 34606957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes After Endovascular Revascularization in Octogenarians and Non-Octogenarians With Critical Limb Ischemia.
    Uhl C; Steinbauer M; Torsello G; Bisdas T;
    J Endovasc Ther; 2017 Aug; 24(4):471-477. PubMed ID: 28578624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.